Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality

Olorunfemi A. Oshagbemi; Frits M. E. Franssen; Dionne C. W. Braeken; Yvonne Henskens; Emiel F. M. Wouters; Anke-Hilse Maitland-van der Zee; Andrea M. Burden; Frank de Vries

doi:10.1002/pds.4655

Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality

Olorunfemi A. Oshagbemi, Frits M. E. Franssen, Dionne C. W. Braeken, Yvonne Henskens, Emiel F. M. Wouters, Anke-Hilse Maitland-van der Zee, Andrea M. Burden, Frank de Vries^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

11 Citations (Web of Science)

Original language	English
Pages (from-to)	1191-1199
Number of pages	9
Journal	Pharmacoepidemiology and Drug Safety
Volume	27
Issue number	11
DOIs	https://doi.org/10.1002/pds.4655
Publication status	Published - Nov 2018

Keywords

chronic obstructive pulmonary disease
eosinophils
exacerbations
inhaled corticosteroids
pharmacoepidemiology
OBSTRUCTIVE PULMONARY-DISEASE
PRACTICE RESEARCH DATALINK
CLINICAL-PRACTICE
COMORBIDITIES
COUNT
PREVENTION
PNEUMONIA
STABILITY
BIOMARKER
MARKERS

Access to Document

10.1002/pds.4655Licence: CC BY-NC

Cite this

Oshagbemi, Olorunfemi A. ; Franssen, Frits M. E. ; Braeken, Dionne C. W. ; Henskens, Yvonne ; Wouters, Emiel F. M. ; Maitland-van der Zee, Anke-Hilse ; Burden, Andrea M. ; de Vries, Frank. / Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality. In: Pharmacoepidemiology and Drug Safety. 2018 ; Vol. 27, No. 11. pp. 1191-1199.

@article{17624a501f7c47a4ab51c2176c991cbe,

title = "Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality",

keywords = "chronic obstructive pulmonary disease, eosinophils, exacerbations, inhaled corticosteroids, pharmacoepidemiology, OBSTRUCTIVE PULMONARY-DISEASE, PRACTICE RESEARCH DATALINK, CLINICAL-PRACTICE, COMORBIDITIES, COUNT, PREVENTION, PNEUMONIA, STABILITY, BIOMARKER, MARKERS",

author = "Oshagbemi, {Olorunfemi A.} and Franssen, {Frits M. E.} and Braeken, {Dionne C. W.} and Yvonne Henskens and Wouters, {Emiel F. M.} and {Maitland-van der Zee}, Anke-Hilse and Burden, {Andrea M.} and {de Vries}, Frank",

year = "2018",

month = nov,

doi = "10.1002/pds.4655",

language = "English",

volume = "27",

pages = "1191--1199",

journal = "Pharmacoepidemiology and Drug Safety",

issn = "1053-8569",

publisher = "Wiley",

number = "11",

}

Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality. / Oshagbemi, Olorunfemi A.; Franssen, Frits M. E.; Braeken, Dionne C. W.; Henskens, Yvonne ; Wouters, Emiel F. M.; Maitland-van der Zee, Anke-Hilse; Burden, Andrea M.; de Vries, Frank.

In: Pharmacoepidemiology and Drug Safety, Vol. 27, No. 11, 11.2018, p. 1191-1199.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality

AU - Oshagbemi, Olorunfemi A.

AU - Franssen, Frits M. E.

AU - Braeken, Dionne C. W.

AU - Henskens, Yvonne

AU - Wouters, Emiel F. M.

AU - Maitland-van der Zee, Anke-Hilse

AU - Burden, Andrea M.

AU - de Vries, Frank

PY - 2018/11

Y1 - 2018/11

KW - chronic obstructive pulmonary disease

KW - eosinophils

KW - exacerbations

KW - inhaled corticosteroids

KW - pharmacoepidemiology

KW - OBSTRUCTIVE PULMONARY-DISEASE

KW - PRACTICE RESEARCH DATALINK

KW - CLINICAL-PRACTICE

KW - COMORBIDITIES

KW - COUNT

KW - PREVENTION

KW - PNEUMONIA

KW - STABILITY

KW - BIOMARKER

KW - MARKERS

U2 - 10.1002/pds.4655

DO - 10.1002/pds.4655

M3 - Article

C2 - 30264901

VL - 27

SP - 1191

EP - 1199

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

SN - 1053-8569

IS - 11

ER -